接受机械通气的危重患者呼吸驱动与镇静深度不一致
该前瞻性队列研究纳入2016-2017年两个2个月期间、美国一家学术医院5个ICU(内科、外科、心脏专科)的56例成年危重患者,均为有创通气启动不超过36小时者,排除影响呼吸功能的神经肌肉疾病或呼气流量受限者。每12±3小时用P0.1(0.1秒气道闭合时气道压变化)测呼吸驱动共3天,同时用Richmond躁动-镇静量表(RASS)评镇静深度。P0.1与RASS无显著相关(Spearman R=0.02;95%CI -0.12~0.16;P=0.80)。按P0.1三分位分组,中间三分位组无呼吸机天数显著多于最低三分位组(发生率比0.78;95%CI 0.65~0.93;P<0.01)和最高三分位组(发生率比0.58;95%CI 0.48~0.70;P<0.01)。结论提示镇静深度不是危重病期间呼吸驱动的可靠标志。
要点
- P0.1与RASS无显著相关(Spearman R=0.02;95%CI -0.12~0.16;P=0.80),镇静深度不能可靠反映呼吸驱动。
- 56例患者共197次床旁评估,P0.1范围0~13.3 cm H2O,中位数0.1 cm H2O(四分位距0.0~1.3 cm H2O)。
- P0.1中间三分位(0.2~1.0 cm H2O)患者无呼吸机天数显著多于最低三分位(<0.2 cm H2O)患者(发生率比0.78;95%CI 0.65~0.93;P<0.01)。
- P0.1中间三分位患者无呼吸机天数显著多于最高三分位(>1.0 cm H2O)患者(发生率比0.58;95%CI 0.48~0.70;P<0.01)。
- 常规目标镇静范围内呼吸驱动可低、中等或高,不能仅凭镇静深度判断自主呼吸努力。
适用人群与场景
- 纳入标准:危重成年患者,有创通气启动不超过入组前36小时。
- 排除标准:影响呼吸功能的神经肌肉疾病或呼气流量受限患者。
- 研究场景:美国一家学术医院5个ICU(代表内科、外科、心脏专科),2016-2017年两个2个月期间入组。
诊断标准与关键阈值
- 呼吸驱动测量:P0.1,即患者吸气努力开始时0.1秒气道闭合期间气道压变化值,每12±3小时测量一次共3天。
- 镇静深度评估:Richmond躁动-镇静量表(RASS)。
- P0.1三分位分组:最低三分位<0.2 cm H2O,中间三分位0.2~1.0 cm H2O,最高三分位>1.0 cm H2O。
研究设计与关键结果
- 研究设计:前瞻性队列研究,纳入56例患者共197次床旁评估,来自美国一家学术医院5个ICU(内科、外科、心脏专科),入组时间为2016-2017年两个2个月期间。
- 主要终点:P0.1与RASS无显著相关(Spearman R=0.02;95%CI -0.12~0.16;P=0.80)。
- P0.1范围0~13.3 cm H2O,中位数0.1 cm H2O(四分位距0.0~1.3 cm H2O)。
- 无呼吸机天数:P0.1中间三分位(0.2~1.0 cm H2O)患者显著多于最低三分位(<0.2 cm H2O)患者(发生率比0.78;95%CI 0.65~0.93;P<0.01)。
- 无呼吸机天数:P0.1中间三分位(0.2~1.0 cm H2O)患者显著多于最高三分位(>1.0 cm H2O)患者(发生率比0.58;95%CI 0.48~0.70;P<0.01)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 镇静深度不是危重病期间呼吸驱动的可靠标志,常规目标镇静范围内呼吸驱动可低、中等或高(作者结论)。
- P0.1与RASS无显著相关,不能仅凭镇静深度判断自主呼吸努力(作者结论)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: In mechanically ventilated patients, deep sedation is often assumed to induce "respirolysis," that is, lyse spontaneous respiratory effort, whereas light sedation is often assumed to preserve spontaneous effort. This study was conducted to determine validity of these common assumptions, evaluating the association of respiratory drive with sedation depth and ventilator-free days in acute respiratory failure.
DESIGN: Prospective cohort study.
SETTING: Patients were enrolled during 2 month-long periods in 2016-2017 from five ICUs representing medical, surgical, and cardiac specialties at a U.S. academic hospital.
PATIENTS: Eligible patients were critically ill adults receiving invasive ventilation initiated no more than 36 hours before enrollment. Patients with neuromuscular disease compromising respiratory function or expiratory flow limitation were excluded.
INTERVENTIONS: Respiratory drive was measured via P0.1, the change in airway pressure during a 0.1-second airway occlusion at initiation of patient inspiratory effort, every 12 ± 3 hours for 3 days. Sedation depth was evaluated via the Richmond Agitation-Sedation Scale. Analyses evaluated the association of P0.1 with Richmond Agitation-Sedation Scale (primary outcome) and ventilator-free days.
MEASUREMENTS AND MAIN RESULTS: Fifty-six patients undergoing 197 bedside evaluations across five ICUs were included. P0.1 ranged between 0 and 13.3 cm H2O (median [interquartile range], 0.1 cm H2O [0.0-1.3 cm H2O]). P0.1 was not significantly correlated with the Richmond Agitation-Sedation Scale (RSpearman, 0.02; 95% CI, -0.12 to 0.16; p = 0.80). Considering P0.1 terciles (range less than 0.2, 0.2-1.0, and greater than 1.0 cm H2O), patients in the middle tercile had significantly more ventilator-free days than the lowest tercile (incidence rate ratio, 0.78; 95% CI, 0.65-0.93; p < 0.01) or highest tercile (incidence rate ratio, 0.58; 95% CI, 0.48-0.70; p < 0.01).
CONCLUSIONS: Sedation depth is not a reliable marker of respiratory drive during critical illness. Respiratory drive can be low, moderate, or high across the range of routinely targeted sedation depth.
参考来源
- Dzierba AL, Khalil AM, Derry KL, et al. Discordance Between Respiratory Drive and Sedation Depth in Critically Ill Patients Receiving Mechanical Ventilation. Crit Care Med. 2021. PMID: 34115638. doi:10.1097/CCM.0000000000005113
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。